English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 179 Help

Selected(0)Clear Items/Page:    Sort:
Identify critical genes of breast cancer and corresponding leading natural product compounds of potential therapeutic targets Journal article
Fan, Xiaokai, Xin, Le, Yu, Xuan, Liu, Maoxuan, Shim, Joong Sup, Yang, Gui, Chen, Liang. Identify critical genes of breast cancer and corresponding leading natural product compounds of potential therapeutic targets[J]. Molecular Diversity, 2024.
Authors:  Fan, Xiaokai;  Xin, Le;  Yu, Xuan;  Liu, Maoxuan;  Shim, Joong Sup; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.9/3.5 | Submit date：2024/12/26
Breast Cancer  Hub Genes  Leading Compounds  Targeted Therapy  
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges Review article
2024
Authors:  Li, Chang Yun;  Wang, Wanhe;  Leung, Chung Hang;  Yang, Guan Jun;  Chen, Jiong
Favorite | TC[WOS]:5 TC[Scopus]:7  IF:27.7/31.3 | Submit date：2024/06/05
Breast Cancer  Histone Demethylation  Kdm5  Kdm5 Inhibitors  Therapeutic Target  
Uncovering immune cell-associated genes in breast cancer: based on summary data-based Mendelian randomized analysis and colocalization study Journal article
Liu, Jingyang, Sun, Wen, Li, Ning, Li, Haibin, Wu, Lijuan, Yi, Huan, Ji, Jianguang, Zheng, Deqiang. Uncovering immune cell-associated genes in breast cancer: based on summary data-based Mendelian randomized analysis and colocalization study[J]. Breast Cancer Research, 2024, 26(1), 172.
Authors:  Liu, Jingyang;  Sun, Wen;  Li, Ning;  Li, Haibin;  Wu, Lijuan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.1/7.1 | Submit date：2024/12/26
Breast Cancer  Bulkrna-seq  Drug Target  Immune Cell  Mendelian Randomization  Scrna-seq  
A NIR iridium(III) complex-based luminescence probe for imaging mitochondria pyruvate dehydrogenase kinase 1 in triple-negative breast cancer cells Journal article
Jing, Shaozhen, Song, Ying Qi, Liu, Jingqi, Zhao, Chen, Wang, Ling, Chan, Daniel Shiu Hin, Wong, Chun Yuen, Lee, Simon Ming Yuen, Wang, Jing, Leung, Chung Hang, Wang, Wanhe. A NIR iridium(III) complex-based luminescence probe for imaging mitochondria pyruvate dehydrogenase kinase 1 in triple-negative breast cancer cells[J]. Sensors and Actuators B: Chemical, 2024, 418, 136265.
Authors:  Jing, Shaozhen;  Song, Ying Qi;  Liu, Jingqi;  Zhao, Chen;  Wang, Ling; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:8.0/7.0 | Submit date：2024/08/05
Breast Cancer  Dichloroacetic Acid (Dca)  Iridium(Iii) Complex  Mitochondrial Targeting  Nir Imaging  Pyruvate Dehydrogenase Kinase 1 (Pdk1)  
Probing the AFF4–CCNT1 protein–protein interaction using a metal–organic conjugate for treating triple-negative breast cancer Journal article
Song, Ying Qi, Xu, Yiwen, Yang, Li Jun, Wang, Ling, Jing, Shaozhen, Yang, Guan Jun, Shiu-Hin Chan, Daniel, Wong, Chun Yuen, Wang, Wanhe, Kam Wai Wong, Vincent, Leung, Chung Hang. Probing the AFF4–CCNT1 protein–protein interaction using a metal–organic conjugate for treating triple-negative breast cancer[J]. Chemical Engineering Journal, 2024, 496, 153685.
Authors:  Song, Ying Qi;  Xu, Yiwen;  Yang, Li Jun;  Wang, Ling;  Jing, Shaozhen; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:13.3/13.2 | Submit date：2024/08/05
Aff4  Ccnt1  Metal–organic Conjugate  Protein–protein Interaction  Triple-negative Breast Cancer  
A Neural Network–Based Scoring System for Predicting Prognosis and Therapy in Breast Cancer Journal article
Deng, Min, Chen, Xinyu, Qiu, Jiayue, Liu, Guiyou, Huang, Chen. A Neural Network–Based Scoring System for Predicting Prognosis and Therapy in Breast Cancer[J]. Current Protocols, 2024, 4(8), e1122.
Authors:  Deng, Min;  Chen, Xinyu;  Qiu, Jiayue;  Liu, Guiyou;  Huang, Chen
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/09/03
Breast Cancer  r  Therapeutic Strategies  Tumor Microenvironment  
Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells Journal article
Cai, Wanhua, Rong, Dade, Ding, Jiayu, Zhang, Xiaomei, Wang, Yuwei, Fang, Ying, Xiao, Jing, Yang, Shulan, Wang, Haihe. Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells[J]. Cancer Cell International, 2024, 24(1), 249.
Authors:  Cai, Wanhua;  Rong, Dade;  Ding, Jiayu;  Zhang, Xiaomei;  Wang, Yuwei; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:5.3/5.0 | Submit date：2024/08/05
Taxane  Perk/eif2α  Tumor Drug Resistance  Breast Cancer  Er Stress  
Texture Analysis of H-scan Ultrasound Images for the Characterization of Breast Tumors Conference paper
Zhanjie Zhang, Sio Hang Pun, Peng Un Mak, Hung Chun Li, Kung Jui Hou, Mang I Vai. Texture Analysis of H-scan Ultrasound Images for the Characterization of Breast Tumors[C]:Springer Science and Business Media Deutschland GmbH, 2024, 302-309.
Authors:  Zhanjie Zhang;  Sio Hang Pun;  Peng Un Mak;  Hung Chun Li;  Kung Jui Hou; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/08/26
Breast Cancer  H-scan  Texture Analysis  Tissue Characterization  Ultrasound Imaging  
αO-Conotoxin GeXIVA[1,2] Suppresses In Vivo Tumor Growth of Triple-Negative Breast Cancer by Inhibiting AKT-mTOR, STAT3 and NF-κB Signaling Mediated Proliferation and Inducing Apoptosis Journal article
Guo, Xijun, He, Leping, Xu, Weifeng, Wang, Wanrong, Feng, Xiaoli, Fu, Yuanfeng, Zhang, Xiaofan, Ding, Ren Bo, Qi, Xingzhu, Bao, Jiaolin, Luo, Sulan. αO-Conotoxin GeXIVA[1,2] Suppresses In Vivo Tumor Growth of Triple-Negative Breast Cancer by Inhibiting AKT-mTOR, STAT3 and NF-κB Signaling Mediated Proliferation and Inducing Apoptosis[J]. Marine Drugs, 2024, 22(6), 252.
Authors:  Guo, Xijun;  He, Leping;  Xu, Weifeng;  Wang, Wanrong;  Feng, Xiaoli; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:4.9/5.2 | Submit date：2024/08/05
Apoptosis  Breast Cancer  Gexiva[1,2]  Proliferation  Αo-conotoxin  
HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis Journal article
Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Qiao-Yan Zhu, Yu-Yang Liao, Xiao-Wen Ding, Lin-Feng Zheng, Wen-Ming Cao. HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16, 1-20.
Authors:  Pu-Chun Li;  Yi-Fan Zhu;  Jia-Ni Pan;  Qiao-Yan Zhu;  Yu-Yang Liao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.3/4.9 | Submit date：2024/07/08
Brca2  Breast Cancer  Her2-negative  Hormone Receptor-positive  Metastatic Breast Cancer  Prognosis